Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $17.75, ...

Analysts have given Pacira BioSciences a total of 7 ratings, with the consensus rating being Buy. The average one-year price target is $18.0, indicating a potential 9.42% upside.

The Smithsonian’s National Zoo and Conservation Biology Institute announced the loss of Kamala, a cherished Asian elephant who served as both a beloved zoo member and an advocate for her species.

This grizzly bear stayed calm while having a health check-up. A veterinary team conducted a tri-annual wellness exam for Huckleberry, a 688-pound (312-kilogram) sedated bear, at Northwest Trek ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...

Inflammatory arthritis is joint inflammation caused by an overactive immune system. It usually affects many joints throughout the body at the same time but could involve just one joint. Inflammatory ...